Search Results for:

Showing 3,921 - 3,930 of 4,361 results

CHA Applauds Court Decision to Move Forward With Implementation of New Liver Allocation Policy

This post has been archived and contains information that may be out of date.

A federal judge has denied a motion to delay implementation of the Acuity Circle Model, the new liver transplantation allocation policy approved by the Organ Procurement and Transplant Network (OPTN) in December 2018. OPTN launched the new liver distribution system on May 14. CHA has long supported this important policy.

More Than 300 Members of Congress Sign Bipartisan Letter Urging Delay of Medicaid DSH Cuts

This post has been archived and contains information that may be out of date.

A total of 302 members of Congress signed on to a bipartisan House letter urging Congress to delay cuts to Medicaid disproportionate share hospitals for at least two years. An overwhelming majority — 48 of 53 — of members of the California delegation cosigned the letter. CHA strongly supports this bipartisan effort and thanks members for their engagement on this critical issue.

White House Considers Mandatory Rate Disclosure

This post has been archived and contains information that may be out of date.

The Trump administration is considering mandating insurers to disclose their negotiated rates for hospital services. This follows a proposal earlier this year that would require hospitals and physicians to inform patients of the full cost of care prior to care being administered.

Protecting Patients, Avoiding Rate Setting

This post has been archived and contains information that may be out of date.

Over the past several weeks, as the 2019 legislative session has kicked into high gear and the political realities for some of our top priorities have become clear, we’ve begun to hone our positions on hot-button issues.

Editorial: People die while the FDA dithers on generic insulin

This post has been archived and contains information that may be out of date.

In 1921, University of Toronto scientists discovered insulin, the pancreas-produced hormone that breaks down sugar in the blood. They quickly purified it, injected it into children dying from Type 1 diabetes, and were hailed as the first great miracle-makers of modern medicine.

There have been many improvements to animal-derived insulin over the years. In 1982, the Food and Drug Administration approved the first DNA-based human insulin.

How the Trump prescription for drug prices transparency could make health care well again

This post has been archived and contains information that may be out of date.

When it comes to the prescription drugs America use, too often money is the last thing consumers think about. Formulaic prescription drug ads are part of the reason why.

Suffer from blood clotting or find yourself at an elevated risk of stroke due to an irregular heartbeat? Then Eliquis is your answer. Got moderate to severe ulcerative colitis, psoriatic arthritis or Crohn’s disease? Then talk to your doctor about Humira.

PhRMA: Drug advertising rules would confuse patients

This post has been archived and contains information that may be out of date.

We agree patients should have more transparency about medicine costs. That is why our member companies have taken a new approach to direct-to-consumer television advertising and began voluntarily directing patients to links to comprehensive cost information in their DTC television advertising.

It is also why we partnered with consumer, patient, pharmacist and provider groups to launch a new platform called the Medicine Assistance Tool at MAT.org. This tool links to the websites referenced in company DTC television advertising and includes a search tool to help patients connect to financial assistance programs.

Draft Federal Legislation Addresses Surprise Billing

This post has been archived and contains information that may be out of date.

The Chair and Ranking Member of the House Energy and Commerce Committee, Reps. Pallone (D-NJ) and Walden (R-OR), released draft legislation to address the issue of surprise billing and asked stakeholders to submit comments by May 28. CHA sent a letter to the California congressional delegation outlining our priorities.

CDPH Changes Approval Process for Sterile Compounding Physical Plant Construction Projects

This post has been archived and contains information that may be out of date.

The California Department of Public Health (CDPH) earlier this week released All Facilities Letter 19-19, which updates its application process for new or remodeled pharmacy clean rooms and mobile sterile compounding units (MSCUs). Notably, CDPH will no longer accept incomplete applications for pharmacy clean rooms or MSCUs. CDPH states the update is in response to Assembly Bill 2978 (Chapter 992, Statutes of 2018), which requires CDPH to review or deny applications within 100 days of receipt.

CHA On-Demand Learning

What’s new in CHA Education? On-demand learning!
CHA is now offering members-only on-demand programs that provide the knowledge you need, on your time schedule. How much time can you spare for learning in a day — 15 minutes? Three hours? The choice is yours.

We’re growing.
Take a look at what we have available and make sure to check back frequently for updates to our library of topics.